A Nontraumatic Hip Fracture in a Young Woman: Cushing’s Disease—Consequences of a Late Diagnosis and Treatment Highlights

[1]  F. Casanueva,et al.  Managing hyperglycemia in patients with Cushing’s disease treated with pasireotide: medical expert recommendations , 2013, Pituitary.

[2]  M. Fleseriu.  Medical management of persistent and recurrent cushing disease. , 2012, Neurosurgery clinics of North America.

[3]  M. Fleseriu,et al.  Medical management of Cushing’s disease: what is the future? , 2012, Pituitary.

[4]  M. Fleseriu,et al.  Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome. , 2012, The Journal of clinical endocrinology and metabolism.

[5]  A. Colao,et al.  A 12-month phase 3 study of pasireotide in Cushing's disease. , 2012, The New England journal of medicine.

[6]  J. Bertherat,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline: commentary from a European perspective. , 2010, European journal of endocrinology.

[7]  G. Arnaldi,et al.  Approach to the patient with possible Cushing's syndrome. , 2009, The Journal of clinical endocrinology and metabolism.

[8]  L. Nieman,et al.  Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. , 2008, The Journal of clinical endocrinology and metabolism.

[9]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[10]  A B Atkinson,et al.  Diagnosis and complications of Cushing's syndrome: a consensus statement. , 2003, The Journal of clinical endocrinology and metabolism.